Original Source(s)
Related Content
Roswell Park Launches Exclusive Phase 1 Clinical Trial of ‘Armored’ CAR T-Cell Therapy for Ovarian Cancer
Roswell Park Comprehensive Cancer Center is currently recruiting for a phase 1 clinical trial of the new therapy (NCT07489287), called GB-5267, which was co-developed by Roswell Park and the therapeutics company Generate:Biomedicines.
June 24, 2026
-
3 min
Study explores adding a low-dose, daily oral chemotherapy for patients with melanoma
UCI Health medical oncologist Poorva Vaidya, MD is currently offering a new clinical trial sponsored by the UC Irvine Anti-Cancer Challenge, and lead by Warren Chow, MD, aimed at tackling a persistent challenge in melanoma care if patients fail first-line immunotherapy.
June 24, 2026
-
1 min
STOPGAP II — a national randomized clinical trial for patients with stage 4 gastric cancer
What starts at UCI Health can help shape the national conversation.
June 30, 2026
-
1 min